2025-25: Psychedelics: What Psychiatric Nurses Should Know and Where They Should Learn It

This presentation will synthesize research on the therapeutic potential of psychedelics in clinical practice, explore the role of nurses and advanced practice nurses in this emerging field, and describe lessons learned from the first year of the University Psychedelic Education Program (U-PEP) for nurse educators.

This presentation is intended for educational purposes only. In no way does this presentation, its author, the accrediting agency, or any aforementioned persons encourage or condone the purchase, sale, transfer, or use of any illegal substances; nor do they encourage or condone partaking in any unlawful activities related to illegal substances. 

This presentation is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read or heard online.

Presenter:  Caroline Dorsen, PhD, FNP-BC, FAAN

Disclosures:  The APNA planners and faculty, with the exception of those listed below, have no relevant financial relationships to disclose. All relevant financial relationships listed for these individuals have been mitigated. Off-label uses will be discussed during this presentation.

Andrew Penn, PMHNP-BC is a consultant for Filament Health, MindMed, Compass Pathways, Tactogen, and Otsuka.

Session Length:  45 minutes

Target Audience:  RN, APRN

Learning Outcome:
Upon completion of this presentation, the participant will be able to:

• Describe two potential therapeutic uses of psychedelics and the role of nurses in this emerging field.

Key Takeaway(s): 

• Emerging evidence suggests that psychedelic-assisted therapy may offer a transformative treatment for challenging mental and physical health conditions, including depression, anxiety, PTSD, addiction, cluster headaches, and neurodegenerative diseases.

Keywords:  Psychedelics, Psychedelic-assisted Therapy, Substance Use, Mental Health 

Nursing Continuing Professional Development:
0.75 contact hours.  * In order to receive contact hours, you must: Listen to the entire presentation, complete the reflection activity, evaluation, and honor statement before the expiration date. Once all steps are successfully completed, a certificate will be generated online and available for you to print immediately. Contact hours cannot be awarded unless all required components are completed. 

The American Psychiatric Nurses Association is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

Release Date:  December 1, 2025
Access to this course will end:  December 1, 2028

*For an uninterrupted learning experience, please download and use Google Chrome, Mozilla Firefox, Microsoft Edge, Safari, etc. If you continue to experience issues, you may need to update your browser.